NEXENTIS TECHNOLOGIES INC. Selling and Marketing Expense
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Selling and Marketing Expense of $34.00 thousand for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2025-11-13
- NEXENTIS TECHNOLOGIES INC. selling and marketing expense for the quarter ending 2025-09-30 was $34.00K, a 47.69% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. selling and marketing expense for the quarter ending 2025-06-30 was $49.00K, a 14.04% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. selling and marketing expense for the quarter ending 2025-03-31 was $47.00K, a 17.54% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. selling and marketing expense for the quarter ending 2024-12-31 was $59.00K, a 9.07% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. selling and marketing expense for fiscal 2024 was $238.00K, a 12.50% decline from fiscal 2023.
- NEXENTIS TECHNOLOGIES INC. selling and marketing expense for fiscal 2023 was $272.00K, a 52.08% decline from fiscal 2022.
- NEXENTIS TECHNOLOGIES INC. selling and marketing expense for fiscal 2022 was $567.60K, a 183.38% increase from fiscal 2021.
- NEXENTIS TECHNOLOGIES INC. selling and marketing expense for fiscal 2021 was $200.30K, a 291.94% increase from fiscal 2020.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $34.00K 10-Q · filed 2025-11-13 | $83.00K derived: sum of 2 quarters · filed 2025-11-13 | $130.00K 10-Q · filed 2025-11-13 | $189.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2025-06-30 | $49.00K 10-Q · filed 2025-08-14 | $95.00K 10-Q · filed 2025-08-14 | $155.00K derived: sum of 3 quarters · filed 2025-08-14 | $220.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2025-03-31 | $47.00K 10-Q · filed 2025-05-15 | $106.00K derived: sum of 2 quarters · filed 2025-05-15 | $171.00K derived: sum of 3 quarters · filed 2025-11-13 | $228.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-12-31 | $59.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $124.00K derived: sum of 2 quarters · filed 2025-11-13 | $181.00K derived: sum of 3 quarters · filed 2025-11-13 | $238.00K 10-K · filed 2025-03-31 | ||||
| 2024-09-30 | $65.00K 10-Q · filed 2025-11-13 | $64.81K 10-Q · filed 2024-11-14 | $122.00K derived: sum of 2 quarters · filed 2025-11-13 | $179.00K 10-Q · filed 2025-11-13 | $179.09K 10-Q · filed 2024-11-14 | $233.09K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $57.00K 10-Q · filed 2025-08-14 | $57.03K 10-Q · filed 2024-08-14 | $114.00K 10-Q · filed 2025-08-14 | $114.28K 10-Q · filed 2024-08-14 | $168.09K derived: sum of 3 quarters · filed 2025-08-14 | $228.56K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $57.00K 10-Q · filed 2025-05-15 | $57.25K 10-Q · filed 2024-05-15 | $111.09K derived: sum of 2 quarters · filed 2025-05-15 | $171.56K derived: sum of 3 quarters · filed 2025-05-15 | $260.33K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $54.09K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $114.56K derived: sum of 2 quarters · filed 2025-03-31 | $203.33K derived: sum of 3 quarters · filed 2025-03-31 | $272.00K 10-K · filed 2025-03-31 | $271.97K 10-K · filed 2024-04-01 | |||
| 2023-09-30 | $60.46K 10-Q · filed 2024-11-14 | $149.24K derived: sum of 2 quarters · filed 2024-11-14 | $217.91K 10-Q · filed 2024-11-14 | $345.82K derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $88.78K 10-Q · filed 2024-08-14 | $157.92K 10-Q · filed 2024-08-14 | $285.36K derived: sum of 3 quarters · filed 2024-08-14 | $402.47K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $69.15K 10-Q · filed 2024-05-15 | $196.59K derived: sum of 2 quarters · filed 2024-05-15 | $313.69K derived: sum of 3 quarters · filed 2024-05-15 | $458.61K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $127.44K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $244.55K derived: sum of 2 quarters · filed 2024-04-01 | $389.46K derived: sum of 3 quarters · filed 2024-04-01 | $567.60K 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | $117.11K 10-Q · filed 2023-11-14 | $262.02K derived: sum of 2 quarters · filed 2023-11-14 | $440.16K 10-Q · filed 2023-11-14 | $538.03K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $144.91K 10-Q · filed 2023-08-14 | $323.05K 10-Q · filed 2023-08-14 | $420.92K derived: sum of 3 quarters · filed 2023-08-14 | $489.94K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $178.14K 10-Q · filed 2023-05-15 | $276.01K derived: sum of 2 quarters · filed 2023-05-15 | $345.03K derived: sum of 3 quarters · filed 2023-05-15 | $363.74K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $97.87K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $166.89K derived: sum of 2 quarters · filed 2023-03-27 | $185.60K derived: sum of 3 quarters · filed 2023-03-27 | $200.30K 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $69.02K 10-Q · filed 2022-11-14 | $87.73K derived: sum of 2 quarters · filed 2022-11-14 | $102.43K 10-Q · filed 2022-11-14 | $139.61K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $18.71K 10-Q · filed 2022-08-15 | $33.41K 10-Q · filed 2022-08-15 | $70.59K derived: sum of 3 quarters · filed 2022-08-15 | $77.33K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $44.26K 10-Q · filed 2022-05-16 | $51.88K derived: sum of 2 quarters · filed 2022-05-16 | $58.62K derived: sum of 3 quarters · filed 2022-05-16 | $66.43K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $7.62K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $14.36K derived: sum of 2 quarters · filed 2022-03-31 | $22.17K derived: sum of 3 quarters · filed 2022-03-31 | $51.10K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $6.73K 10-Q · filed 2021-11-15 | $14.54K derived: sum of 2 quarters · filed 2021-11-15 | $43.48K 10-Q · filed 2021-11-15 | $6.93K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $7.81K 10-Q · filed 2021-08-16 | $36.75K 10-Q · filed 2021-08-16 | $196.00 derived: sum of 3 quarters · filed 2021-08-16 | $120.64K derived: sum of 4 quarters · filed 2021-08-16 | ||||
| 2020-03-31 | $28.94K 10-Q · filed 2021-05-18 | -$7.62K derived: sum of 2 quarters · filed 2021-05-18 | $112.83K derived: sum of 3 quarters · filed 2021-05-18 | $224.43K derived: sum of 4 quarters · filed 2021-05-18 | ||||
| 2019-12-31 | -$36.55K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $83.90K derived: sum of 2 quarters · filed 2021-03-29 | $195.50K derived: sum of 3 quarters · filed 2021-03-29 | $342.06K 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $120.45K 10-Q · filed 2020-11-12 | $232.05K derived: sum of 2 quarters · filed 2020-11-12 | $378.61K 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | $111.60K 10-Q · filed 2020-08-11 | $258.16K 10-Q · filed 2020-08-11 | ||||||
| 2019-03-31 | $146.56K 10-Q · filed 2020-05-15 | |||||||
| 2018-12-31 | $140.73K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |